CGEN
Compugen Ltd.
NASDAQ · Healthcare · Biotechnology · IL
$2.00
−2.21%Sep 22, 2026, 11:00 UTC
Compugen Ltd. announced it will host a virtual key opinion leader event on October 5, 2026, covering COM701 in ovarian cancer and an update on its Unigen platform.
Source:Aug 3, 2026, 11:00 UTC
Compugen reported its financial results for the second quarter of 2026, highlighting a solid financial position with cash runway expected to fund operations into 2029.